Tesla sold 8,621 cars in China in July, accounting for just 3.9 percent sales of battery electric vehicles in the country, down nearly 70 percent from its 12.6 percent share in June, according to the China Passenger Car Association.
Analyst Gordon Johnson said that Tesla overbuilt Chinese capacity when compared to domestic demand, which will result in further price cuts and margin pressure.
But Tesla investors seemed unfazed by the sales decline, with shares dropping less than 2 percent in early trading Tuesday.
Last month, Tesla exhibited that its declining numbers in China didn't stop it from posting better than expected global sales for the full quarter, according to Wedbush Securities tech analyst Dan Ives. He noted that its numbers in China had not been the best indicator of Tesla's success.
Nonetheless, Ives warned that if Tesla's sales in China don't improve, it could eventually face serious problems.
Meanwhile, the export of Tesla cars built at its Shanghai plant soared to 24,347 for July, compared with 5,017 in June.


TSMC Honors Japanese Chip Equipment Makers With 2025 Supplier Awards
Nike Stock Jumps After Apple CEO Tim Cook Buys $2.9M Worth of Shares
Winter Storm Devin Triggers Massive Flight Cancellations and Travel Disruptions Across the U.S.
Argentina Congress Approves 2026 Budget Under Milei, Marking First Legislative Passage Since 2023
Asian Markets Rise as AI Rally Caps 2025, Gold and Silver Hit Record Highs
US and Japan Fast-Track $550 Billion Strategic Investment Initiative
Oil Prices Rise on Venezuela Sanctions and Nigeria Airstrikes Despite Annual Losses
Mexico Antitrust Review of Viva Aerobus–Volaris Deal Signals Growth for Airline Sector
China Industrial Profits Slump Signals Need for More Economic Stimulus
Nvidia to Acquire Groq in $20 Billion Deal to Boost AI Chip Dominance
California Regulator Probes Waymo Robotaxi Stalls During San Francisco Power Outage
DOJ Reaches Settlement With Blackstone’s LivCor Over Alleged Rent Price-Fixing
China Revises 2024 GDP Lower After Final Review, Eyes Growth in 2025
Russian Stocks End Lower as Energy and Mining Shares Weigh on MOEX Index
Boeing Wins $2.04B U.S. Air Force Contract for B-52 Engine Replacement Program
FDA Approves Mitapivat for Anemia in Thalassemia Patients
Gold and Silver Hit Record Highs as Safe-Haven Demand Surges Amid Global Uncertainty 



